UK markets closed

BioInvent International AB (publ) (0H22.IL)

IOB - IOB Delayed price. Currency in SEK
Add to watchlist
26.67+1.52 (+6.06%)
At close: 05:15PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
61,153
71,461
326,126
19,384
147,372
Operating expenses
Research development
388,354
390,434
325,929
258,337
191,421
Selling general and administrative
52,488
51,606
50,750
39,438
32,155
Total operating expenses
440,485
442,018
376,598
297,549
222,329
Operating income or loss
-379,332
-370,557
-50,472
-278,165
-74,957
Interest expense
-
638
650
517
335
Income before tax
-334,283
-330,100
-42,503
-278,444
-76,333
Income tax expense
235
204
0
0
0
Income from continuing operations
-334,518
-330,304
-42,503
-278,444
-76,333
Net income
-334,518
-330,304
-42,503
-278,444
-76,333
Net income available to common shareholders
-334,518
-330,304
-42,503
-278,444
-76,333
Basic EPS
-4.78
-
-0.69
-5.14
-2.66
Diluted EPS
-4.78
-
-0.69
-5.14
-2.66
Basic average shares
65,804
-
61,521
54,161
28,716
Diluted average shares
65,804
-
61,521
54,161
28,716